<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We tested the hypothesis whether the partially duplicated variant of alpha7 nicotinic <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> receptor subunit gene (CHRFAM7A) 2-bp deletion (-2 bp) polymorphism and <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE) epsilon4 allele confer susceptibility to <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e>), <z:e sem="disease" ids="C0236642" disease_type="Disease or Syndrome" abbrv="">Pick's disease</z:e> (PiD) and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VD) </plain></SENT>
<SENT sid="1" pm="."><plain>The study included 175 AD, 35 DLB patients, 38 PiD, 96 VD and 175 healthy control (HC) probands </plain></SENT>
<SENT sid="2" pm="."><plain>The CHRFAM7A genotype without the -2 bp allele was significantly over-represented in AD (p = 0.011), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> (p = 0.001) and PiD (p &lt; 0.0001) compared to HC, but there were no statistical differences in VD (p = 0.407) compared to HC </plain></SENT>
<SENT sid="3" pm="."><plain>We confirmed again that the ApoE epsilon4 allele is a risk factor for <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The -2 bp polymorphism of CHRFAM7A can be implicated in AD, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLB</z:e> and PiD </plain></SENT>
<SENT sid="5" pm="."><plain>However, it is unlikely that it plays an important role in the pathogenesis of VD </plain></SENT>
</text></document>